Navigation Links
Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”
Date:1/14/2014

Rochester, NY (PRWEB) January 14, 2014

During the 1600’s through the 1800’s doctors contributed unknowingly to what is now known as “The Doctor’s Plague.” In this time period, doctors did not know that they needed to wash their hands. This led, at times, to the death of vulnerable patients. In the same way, medical interns and hospital staff today don’t know that they may be unwittingly transmitting herpes viruses to their patients. The CBCD explains.

A study showed that severe fatigue contributed to latent herpes virus reactivation in modern medical interns. The reactivated virus was then transmitted unknowingly to patients as medical interns made their rounds. The study was published on November 9, 2011 in the journal of Interdisciplinary Perspectives on Infectious Diseases (2).

Study authors wrote that “Chronic exposure to complex cognitive and noncognitive stressors (during medical residency) can progress to distress (and) leads to general fatigue (which) has been shown to alter immune responsiveness and (lead to) reactivation of the latent herpes viruses… (2).” In other words, medical interns are exposed to situations that cause extreme fatigue. This fatigue weakens the immune system, which in turn, reactivates the latent herpes virus.

“Physicians, especially those in training, typically work long hours and are often fatigued due to sleep deprivation; fatigue contributes to the human component of medical errors and, thus, jeopardizes patient safety. Decrease in cognitive function was observed among Ob/Gyn residents and medical students … (2).” Moreover, study authors wrote that in these medical interns, “We have detected reactivation of latent herpes viruses that suggests immune suppression (2).”

Reactivation of latent herpes viruses in medical interns places patients at risk. As the study notes, “Fatigue among residents and increased shedding of herpes virus DNA are the major findings of thi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Study: Risk of Acquiring Genital Warts in the Mouth from Sex is 50%; polyDNA Recommends Targeting Latent HPV with Gene-Eden-VIR
2. Study: RSV often milder than flu in older adults
3. Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
4. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
5. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
6. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
7. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
8. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
9. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Nature Materials study: Boosting heat transfer with nanoglue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... will provide new insights on mechanics of fecal microbiota transplantation in C. difficile ... study the microbiome of patients undergoing fecal microbiota transplantation (FMT) as a treatment ...
(Date:6/30/2015)... , June 30, 2015  The University of ... Biosciences (CCE/Bio) and UC San Diego Extension announced ... be held Aug.  12 – 14, 2015, at ... three-day workshop provides an intense exposure to best ... and is well-suited to biologists, process engineers and ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... prior to launching SmartArch — a revolutionary new archwire that allows orthodontists to ... further clinical evidence of the efficacy of SmartArch. “We’re thrilled about taking SmartArch ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2New case studies for SmartArch orthodontic archwire paves way to product launch later this year 2
... OAKS, Calif., June 24, 2011 Amgen (NASDAQ: ... Medicinal Products for Human Use (CHMP) of the European ... that Vectibix® (panitumumab) be approved for use in the ... and in second-line in combination with FOLFIRI in patients ...
... are exposed to light, they blink in a ... at the University of Pennsylvania have shown that ... new insight into this mysterious blinking behavior. ... Drndic,s group, including graduate student Siying Wang and ...
... BioNeutral Group Inc., (OTCBB: BONU.ob) today announced it ... of their revolutionary Cold Sterilant and Cleaning/Odor Products ... selected by New Jersey based T.U.C.S. Cleaning Services ... distribution company, because of the superior effectiveness of ...
Cached Biology Technology:Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 2Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 3Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 4Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 5Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 6Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 7Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 8Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 9Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy 10Penn physicists observe 'campfire effect' in blinking nanorod semiconductors 2Penn physicists observe 'campfire effect' in blinking nanorod semiconductors 3BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 2BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 3BioNeutral Starts Commercial Deployment of Its Ygiene 206 Sterilant and Ogiene Products Within Port Authority Facilities Using T.U.C.S. Cleaning Services 4
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/30/2015)... 2015 Genisphere announced Tom ... help further develop Genisphere,s therapeutics capabilities and portfolio. Mr. ... spent much of the last 25 years in leadership ... and Johnson & Johnson. Tom started his career in ... Corporate Finance. He graduated from Dartmouth College with a ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... from the Luxembourg Centre for Systems Biomedicine (LCSB) of ... in the brain can produce a substance that prevents ... assumed that only certain fungi produced itaconic acid. A ... Metabolomics Group at LCSB, and Dr. Alessandro Michelucci has ...
... reporting new outbreaks and the increased spread of Cassava Brown ... virus could cause a 50 percent drop in production of ... income for 300 million Africans. , The "pandemic" of ... been looking to the otherwise resilient cassava plantwhich is also ...
... scientists, writing in the journal Nature Geoscience , have ... an unexpected cooling effect on the world,s climate by making ... on to tiny particles suspended in the air. When the ... It has been known for some decades that the number ...
Cached Biology News:LCSB discovers endogenous antibiotic in the brain 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 3Scientists alarmed by rapid spread of Brown Streak Disease in cassava 4Organic vapors affect clouds leading to previously unidentified climate cooling 2
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
... Although the mixed TAMRA isomers are ... isomers are increasingly preferred for labeling peptides ... in HPLC purification that is often required ... often used than 6-TAMRA for labeling peptides ...
anti-Lactate Dehydrogenase...
Biology Products: